Last Price
393.70
Today's Change
+2.63 (0.67%)
Day's Change
393.70 - 398.71
Trading Volume
48,338
Market Cap
12 Billion
Shares Outstanding
30 Million
Avg Volume
285,698
Avg Price (50 Days)
398.06
Avg Price (200 Days)
306.74
PE Ratio
40.09
EPS
9.82
Earnings Announcement
22-Jul-2024
Previous Close
391.07
Open
396.79
Day's Range
393.7 - 398.715
Year Range
197.39 - 421.0
Trading Volume
48,361
1 Day Change
0.67%
5 Day Change
0.51%
1 Month Change
-0.61%
3 Month Change
33.17%
6 Month Change
43.58%
Ytd Change
28.83%
1 Year Change
91.60%
3 Year Change
134.29%
5 Year Change
581.73%
10 Year Change
1316.70%
Max Change
1316.70%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.